The short version
4 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $186.38 per unit over the past year.
Market view
alteplase
9 marketed package NDCs · 4 active manufacturers
Most dispensed: 2.2 mg/2mL · Injection, Powder, Lyophilized, For Solution · #1 vial/carton / 2 ml in 1 vial
Price range and competition
RSS: changes for this drugEvery company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.
Latest · Jul 2026 — typical price $186.38 · middle half $186.38–$186.38 · full range $186.38–$186.38 · 1 products · 4 companies
ⓘ How this was built
Data sources
- CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
- CMS Federal Upper Limit files (weighted AMP)
- FDA NDC Directory (openFDA) — maker roster
Method
Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Common questions
- Is Alteplase in shortage right now?
- No. FDA does not currently list Alteplase in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Alteplase?
- 4 companies have marketed Alteplase in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.